New Releases from NCBI BookshelfRamucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal).Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal).
Post Content
